536565 TRIMURTHI

Novelix Pharmaceuticals Share Price

 

 

Start SIP in TRIMURTHI

Start SIP

Performance

  • Low
  • ₹60
  • High
  • ₹64
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹70
  • Open Price₹60
  • Previous Close₹63
  • Volume9,045
  • 50 DMA₹58.16
  • 100 DMA₹53.93
  • 200 DMA₹45.29

Investment Returns

  • Over 1 Month + 9.41%
  • Over 3 Month + 13.57%
  • Over 6 Month + 49.24%
  • Over 1 Year + 147.26%

Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!

Invest Now

Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 113.8
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 110
  • P/B Ratio
  • 3.8
  • Average True Range
  • 3.59
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.8
  • RSI
  • 60.41
  • MFI
  • 70.71

Novelix Pharmaceuticals Financials

Novelix Pharmaceuticals Technicals

EMA & SMA

Current Price
₹62.68
-0.3 (-0.48%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹60.08
  • 50 Day
  • ₹58.16
  • 100 Day
  • ₹53.93
  • 200 Day
  • ₹45.29

Resistance and Support

61.93 Pivot Speed
  • R3 67.25
  • R2 65.13
  • R1 64.05
  • S1 60.85
  • S2 58.73
  • S3 57.65

Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results & A.G.M.
2025-06-24 Others Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company.
2025-05-27 Audited Results

Novelix Pharmaceuticals F&O

Novelix Pharmaceuticals Shareholding Pattern

50.8%
44%
5.2%

Novelix Pharmaceuticals FAQs

Novelix Pharmaceuticals share price is ₹62 As on 11 February, 2026 | 17:31

The Market Cap of Novelix Pharmaceuticals is ₹110.4 Cr As on 11 February, 2026 | 17:31

The P/E ratio of Novelix Pharmaceuticals is 113.8 As on 11 February, 2026 | 17:31

The PB ratio of Novelix Pharmaceuticals is 3.8 As on 11 February, 2026 | 17:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23